Store → Pharmaceutical Products → Pharmaceuticals, Medicinal Chemical And Botanical Products → Medicaments Containing Insulin But Not Antibiotics

Report Update: Sep 1, 2023

Netherlands - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$499 Basic Edition $1995 Professional Edition

What's the difference?

Netherlands: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in the Netherlands

The Dutch medicaments containing insulin market soared to $X in 2021, jumping by 25,131% against the previous year. Over the period under review, consumption recorded strong growth. Over the period under review, the market reached the maximum level at $X in 2019; however, from 2020 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in the Netherlands

In value terms, medicaments containing insulin production stood at $X in 2021 estimated in export price. Over the period under review, production continues to indicate a sharp decrease. The pace of growth appeared the most rapid in 2019 with a decrease of -11.8% against the previous year. Over the period under review, production reached the maximum level at $X in 2017; however, from 2018 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from the Netherlands

In 2021, approx. X kg of medicaments containing insulin but not antibiotics were exported from the Netherlands; waning by -50.5% on the previous year. In general, exports recorded a dramatic decrease. The smallest decline of -37.9% was in 2019. The exports peaked at X tons in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports surged to $X in 2021. Overall, exports showed a dramatic slump. Over the period under review, the exports attained the maximum at $X in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

Exports by Country

The UK (X kg) was the main destination for medicaments containing insulin exports from the Netherlands, with a 63% share of total exports. Moreover, medicaments containing insulin exports to the UK exceeded the volume sent to the second major destination, the Czech Republic (X kg), fivefold. Germany (X kg) ranked third in terms of total exports with a 7.4% share.

From 2017 to 2021, the average annual rate of growth in terms of volume to the UK stood at +652.4%. Exports to the other major destinations recorded the following average annual rates of exports growth: the Czech Republic (+87.1% per year) and Germany (-86.0% per year).

In value terms, the UK ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from the Netherlands, comprising 71% of total exports. The second position in the ranking was held by the Czech Republic ($X), with a 15% share of total exports. It was followed by Poland, with a 9.6% share.

From 2017 to 2021, the average annual rate of growth in terms of value to the UK stood at +6,321.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: the Czech Republic (+538.6% per year) and Poland (+10.9% per year).

Export Prices by Country

In 2021, the average medicaments containing insulin export price amounted to $X per ton, rising by 433% against the previous year. In general, the export price saw a significant expansion. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major overseas markets. In 2021, amid the top suppliers, the country with the highest price was Poland ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2017 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Poland (+1,370.2%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports into the Netherlands

In 2021, the amount of medicaments containing insulin but not antibiotics imported into the Netherlands skyrocketed to X tons, with an increase of 20% against 2020. Over the period under review, imports showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2019 when imports increased by 1,876% against the previous year. As a result, imports attained the peak of X tons. From 2020 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing insulin imports reduced remarkably to $X in 2021. Overall, imports continue to indicate a remarkable increase. The most prominent rate of growth was recorded in 2019 with an increase of 2,192%. As a result, imports reached the peak of $X. From 2020 to 2021, the growth of imports failed to regain momentum.

Imports by Country

In 2021, Belgium (X tons) constituted the largest supplier of medicaments containing insulin to the Netherlands, accounting for a 90% share of total imports. Moreover, medicaments containing insulin imports from Belgium exceeded the figures recorded by the second-largest supplier, the UK (X kg), more than tenfold.

From 2012 to 2021, the average annual rate of growth in terms of volume from Belgium amounted to -55.2%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (0.0% per year) and Estonia (-32.1% per year).

In value terms, Belgium ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to the Netherlands, comprising 78% of total imports. The second position in the ranking was held by Estonia ($X), with a 15% share of total imports.

From 2012 to 2021, the average annual growth rate of value from Belgium amounted to -40.8%. The remaining supplying countries recorded the following average annual rates of imports growth: Estonia (-11.8% per year) and the UK (0.0% per year).

Import Prices by Country

In 2021, the average medicaments containing insulin import price amounted to $X per ton, reducing by -68.5% against the previous year. Over the period under review, the import price, however, enjoyed a remarkable increase. The pace of growth appeared the most rapid in 2020 when the average import price increased by 454% against the previous year. As a result, import price reached the peak level of $X per ton, and then shrank dramatically in the following year.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Estonia ($X per ton), while the price for the UK ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belgium (+32.1%).

Source: IndexBox Platform

Base Year	Historical Period	Forecast Period	Units
2022	2012-2022	2023-2030	US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

The countries with the highest volumes of consumption in 2021 were the United States, Denmark and Germany, with a combined 72% share of global consumption.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin production was the United States, accounting for 67% of total volume. Moreover, medicaments containing insulin production in the United States exceeded the figures recorded by the second-largest producer, Germany, fivefold. India ranked third in terms of total production with a 5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to the Netherlands?

In value terms, Belgium constituted the largest supplier of medicaments containing insulin but not antibiotics to the Netherlands, comprising 78% of total imports. The second position in the ranking was taken by Estonia, with a 15% share of total imports.

What are the leading importers of medicaments containing insulin but not antibiotics from the Netherlands?

In value terms, the UK emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from the Netherlands, comprising 71% of total exports. The second position in the ranking was held by the Czech Republic, with a 15% share of total exports. It was followed by Poland, with a 9.6% share.

What is the average export price for medicaments containing insulin but not antibiotics in the Netherlands?

In 2021, the average medicaments containing insulin export price amounted to $362,895 per ton, picking up by 433% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in the Netherlands?

In 2021, the average medicaments containing insulin import price amounted to $27,018 per ton, declining by -68.5% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in the Netherlands. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

• Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

• Netherlands

Data coverage:

• Market volume and value

• Per Capita consumption

• Forecast of the market dynamics in the medium term

• Trade (exports and imports) in the Netherlands

• Export and import prices

• Market trends, drivers and restraints

• Key market players and their profiles

Reasons to buy this report:

• Take advantage of the latest data

• Find deeper insights into current market developments

• Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

1. How to diversify your business and benefit from new market opportunities

2. How to load your idle production capacity

3. How to boost your sales on overseas markets

4. How to increase your profit margins

5. How to make your supply chain more sustainable

6. How to reduce your production and supply chain costs

7. How to outsource production to other countries

8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1

REPORT DESCRIPTION

1.2

RESEARCH METHODOLOGY AND AI PLATFORM

1.3

DATA-DRIVEN DECISIONS FOR YOUR BUSINESS

1.4

REPORT DESCRIPTION

2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance